Improving Survivorship for Critically Ill Patients Aged 65 and Over
Trial statusNot yet recruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age65+
SponsorAustralian and New Zealand Intensive Care Research Centre
About this trial
IMPROVE-65 is a randomised control trial designed specifically for people aged over 65 who have survived critical illness. It aims to support patients and general practitioners by providing timely, personalised information to help them work together to make informed goals and decisions about their care after hospital discharge. The aim of the study is to improve recovery and avoid preventable hospital readmissions.
Eligibility criteria
Qualifiers
Was admitted to ICU for at least 48 hours
is aged 65 years or older at the time of hospital admission
Is alive and ready for hospital discharge
Is expected to survive for 6 months beyond hospital discharge (e.g. not discharged on palliative care)
Disqualifiers
Is not expected to reside in Australia for 3 months following randomisation.
Is not expected to be living at home within 2 weeks of acute hospital discharge (e.g. prolonged inpatient rehabilitation)
Is unable to identify a GP or GP clinic and/or are unable or unwilling to attend a GP appointment scheduled by the recovery navigator.
Has an existing recovery or nurse navigator as part of their routine clinical care to assist with planning their care after hospital discharge
Trial design
Treatments tested in this trial
- Multicomponent telehealth care coordination
Treatment groups
300 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov